Company
Since 1909, Grifols has worked to improve the health and well-being of people around the world.
Corporate Structure
Innovation
Grifols is full speed ahead on developing the next innovative breakthroughs across multiple therapeutic areas.
Sustainability
Grifols' longstanding commitment to people and the planet entails helping society on all fronts.
Investors
Stock Information
Financials
Communications with CNMV and SEC
Corporate Governance
Careers
People are at the heart of our business. We are committed to continued investment in training and development.
Media
Latest news about the company and contact information for journalists and communication professionals.
Partners
At Grifols, we believe in long-term, mutually trusting relationships with our partners.
Connect with us
The financial results published by the company can be downloaded in PDF format in this section.
Second Quarter 2025 Results
First Quarter 2025 Results
Full-Year 2024 Results
Third Quarter 2024 Results
Second Quarter 2024 Results
First Quarter 2024 Results
Full Year 2023 Results
Third Quarter 2023 Results
Second Quarter 2023 Results
First Quarter 2023 Results
Full Year 2022 Results
Business update - Third quarter 2022
First Half 2022 Results
Business update - First quarter 2022
Full year 2021 report
Business Update – Third Quarter 2021
2021 first half report
2021 first quarter report
2020 second half report
2020 third quarter report
2020 first half report
2020 first quarter report
2019 second half report
2019 third quarter report
2019 first half report
2019 first quarter report
2018 second half report
2018 third quarter report
2018 first half report
2018 first quarter report
2017 second half report
2017 third quarter report
2017 first half report
2017 first quarter report
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
You're now inReduced Motion Mode
You can change back to motion enhanced mode at the top of the page.